Compare ARK Genomic Revolution ETF (ARKG) vs ProShares UltraPro QQQ ETF (TQQQ) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs ProShares UltraPro QQQ ETF — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while ProShares UltraPro QQQ ETF trades at $74.8. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, ProShares UltraPro QQQ ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | TQQQ | |
|---|---|---|
Sector | Sector/Thematic | Leveraged / Inverse |
52-Week High | $43.57 | $87.22 |
52-Week Low | $23.09 | $37.89 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
TQQQ (ProShares UltraPro QQQ) trades at $77.03, up 0.9% with a bullish technical signal from moving averages. The leveraged ETF amplifies Nasdaq-100 returns by 3x daily, showing strong historical performance but significant volatility risks. Recent news highlights concerns about leveraged ETFs amplifying market volatility while acknowledging their potential for substantial gains during bull markets.
The outlook remains tied to Nasdaq-100 performance with opportunities for amplified returns in trending markets, but structural costs and volatility decay pose significant risks during market downturns. Investors face asymmetric risk-reward dynamics requiring careful position sizing and risk management strategies.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About ProShares UltraPro QQQ ETF
TQQQ is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the Nasdaq-100 Index. It is one of the most liquid and actively traded instruments in the market, designed for sophisticated traders to amplify short-term bullish exposure to large-cap non-financial growth stocks, predominantly in the technology and communication sectors.
Read more on TQQQ →
